Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,525,764
+$300,482 QoQ
Shares Held
18,021
+1.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#711
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. AMGN ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
This page
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,525,764 | 18,021 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $6,225,282 | 17,693 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,542,994 | 16,935 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,503,912 | 15,960 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $4,052,453 | 14,514 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $4,515,917 | 14,495 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,556,954 | 13,647 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $4,355,956 | 13,519 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,181,517 | 13,383 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $4,273,329 | 15,030 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,182,626 | 14,522 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,855,630 | 14,346 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,097,400 | 13,951 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,727,181 | 11,281 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $3,519,901 | 13,402 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,987,226 | 13,253 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,136,866 | 12,893 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $3,684,853 | 15,238 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,989,175 | 13,287 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,918,620 | 13,725 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,581,173 | 14,692 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $3,752,549 | 15,082 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,709,757 | 16,135 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $4,036,567 | 15,882 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $3,679,179 | 15,599 | Shares | Other | 2020-07-10 | |
| 2020-03-31 | $2,333,015 | 11,508 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||